Jing Shang is a Senior Principal Scientist at Pfizer, specializing in ligand binding assays, biosensors, and nanotechnology. They earned a PhD in Bioengineering from the University of Washington, where they developed novel bioconjugation strategies and characterized biomolecular interactions. With a background in Polymer Chemistry and Physics from Fudan University and extensive experience in various scientific roles, they have contributed to advancements in cancer diagnostics and analytical method development. They have previously held positions at Seagen and NanoString Technologies, among others.
This person is not in the org chart
This person is not in any teams
This person is not in any offices